phenylbutyric acid
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 31, 2019 (NCT04093115)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- ammonium ionBINDING AGENT
ammonium ion binding agent
Chemistry & pharmacology
Loading structure…
SMILES
CCCC(=O)O- Mol. weight
- 88.11 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL14227 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07289581 | N/A | Nov 12, 2025 | University of Florence |
| NCT04093115 | Phase 2 | Oct 31, 2019 | Beijing Konruns Pharmaceutical Co., Ltd., Chinese Academy of Medical Sciences, Tsinghua University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Beijing Konruns Pharmaceutical Co., Ltd. | For profit | 1 | 1 | 1 | 2019 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Tsinghua University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of Florence | Academic/Hospital | 1 | 1 | 1 | 2025 |
4 organizations
Page 1 / 1